Results 171 to 180 of about 15,176 (256)

Twice-daily bictegravir during rifampicin-based tuberculosis therapy: A pragmatic alternative. [PDF]

HIV Med
Sánchez-Cano JG, Muñoz-Echeverría L, Casco-García M, Moreno-Núñez L.   +3 more
europepmc   +1 more source

Machine Learning-Driven Discovery of Indole/Oxoindole-Piperazine Scaffolds as Dual MAO-B/Sig-1R Ligands for Neurodegenerative Disorders. [PDF]

J Chem Inf Model
da Silva UC, Ferreira MS, Alves EB, Paixão VVM, Lapa IR, Nogueira MMB, Rodrigues RP, Almeida WP, Soares MG, Chagas-Paula DA, Katchborian-Neto A, Oliveira TB, Dias DF.   +12 more
europepmc   +1 more source

Trends in new psychoactive substance poisonings in the Netherlands: A 14-year retrospective analysis (2012-2025). [PDF]

Addiction
Nugteren-van Lonkhuyzen JJ, van den Hengel-Koot IS, Hunault CC, de Lange DW, van Riel AJHP, Hondebrink L.   +5 more
europepmc   +1 more source

Defining the mechanism of action of the nitrofuranyl piperazine HC2210 against Mycobacterium abscessus. [PDF]

NPJ Antimicrob Resist
Eke IE, Abdalla BJ, Soverina S, Olive AJ, Cicchetti N, Carey AF, Abramovitch RB.   +6 more
europepmc   +1 more source

Development of green purification process for piperazine-type drugs: a case study of quetiapine process development. [PDF]

RSC Adv
Huang W, Wang Y, Liu H, Li H, Yin Q.
europepmc   +1 more source

Eugenol-Derived Piperazine Mannich Bases as Selective Inhibitors of Mayaro Virus: In Vitro Antiviral Evaluation and Mechanistic Insights. [PDF]

J Med Virol
Reis ACC, Silva ALSD, Portruneli C, Silva AVP, Braga SFP, Lapa IR, Souza TB, Franco LL, Carvalho DT, Brandão GC.   +9 more
europepmc   +1 more source

A Novel BRCA1 Pathogenic Variant in Tunisian Patient With High Grade Ovarian Cancer: Favorable Therapeutic Response to Olaparib. [PDF]

Cancer Rep (Hoboken)
Ammous-Boukhris N, Abdelmaksoud-Dammak R, Feki A, Khemiri S, Charfi S, Sallemi-Boudawara T, Daoud J, Khanfir A, Gargouri RM.   +8 more
europepmc   +1 more source

Monitoring of new psychoactive substances in France: update of addictovigilance data. [PDF]

Eur J Public Health
Autellet A, Lacroix C, Batisse A, Micallef J, Fouilhe N, Le Boisselier R, Peyrière H, Eiden C, French Addictovigilance Network.   +8 more
europepmc   +1 more source

Novel 1-(2-Aryl-2-adamantyl)piperazine Derivatives Exhibit In Vitro Anticancer Activity Across Various Human Cancer Cell Lines, with Selective Efficacy Against Melanoma. [PDF]

Medicina (Kaunas)
Papapostolou I, Sereti E, Chatira S, Sakellaridis N, Fytas G, Zoidis G, Dimas K.   +6 more
europepmc   +1 more source

Piperazine [PDF]

, 2020
openaire   +1 more source